Market Overview

UPDATE: Morgan Stanley Reiterates on Walgreen Company on 2QFY14 Earnings Preview

Related WAG
UPDATE: Walgreens Boots Alliance Filing Shows Prelim. Proxy Statement Related to Strategic Transaction
Will Rite Aid (RAD) Miss Estimates this Earnings Season?
Will the Prez Call Out…The Oracle? (Fox Business)

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $68.00 price target.

In the report, Morgan Stanley noted, “WAG shares up 17% since January and holding on to gains March to-date, heading into what is likely to be soft earnings as investors focus on LT opportunities. Key to share performance will be mgmt commentary regarding synergies, timing of step 2 of AB deal, and strategic direction.”

Walgreen Company closed on Tuesday at $67.20.

Latest Ratings for WAG

DateFirmActionFromTo
Aug 2014Bank of AmericaUpgradesUnderperformNeutral
Aug 2014Cantor FitzgeraldUpgradesSellHold
Aug 2014JefferiesMaintainsBuy

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (WAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters